US equities
|
ANT
$96.72
▲+16.53%
NVDA
$149.04
▼-1.27%
AMD
$487.56
▼-8.03%
MU
$704.72
▼-0.08%
SPCX
$137.91
▼-3.90%
SNDK
$776.17
▼-0.01%
AMZN
$260.13
▼-2.84%
MSFT
$504.27
▼-0.79%
ANT
$96.72
▲+16.53%
NVDA
$149.04
▼-1.27%
AMD
$487.56
▼-8.03%
MU
$704.72
▼-0.08%
SPCX
$137.91
▼-3.90%
SNDK
$776.17
▼-0.01%
AMZN
$260.13
▼-2.84%
MSFT
$504.27
▼-0.79%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
MNMD
Penny Stocks
Benzinga
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
NDAQ
MindMed
J/R/ Rahn
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
StartEngine
Kevin O'Leary
Jordan Fried
From
Benzinga